Buy One Get One free -Llimited Time Offer X
Adriblastina is a prescription medicine that is available as a Injection. It is typically used for the treatment of Blood Cancer. Secondary and off-label uses of Adriblastina have also been mentioned below.
The right dosage of Adriblastina depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Adriblastina include Hair Loss. Besides the aforementioned side effects, there are other adverse effects of Adriblastina as well, which are listed below. Normally, these side effects of Adriblastina are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Adriblastina's effect during pregnancy is Severe and Severe while nursing. In addition, Adriblastina's effects on the liver, heart and kidney are discussed below in the Adriblastina related warnings section.
Adriblastina is contraindicated in people with pre-existing medical conditions like Heart Failure as it can result in adverse effects. Other contraindications of Adriblastina have been discussed in the sections ahead.
Drug reaction of Adriblastina with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Adriblastina is not safe while driving, and is is not addictive in nature.
Adriblastina is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Adult(Female) |
|
Geriatric |
|
Based on research, the following side effects have been observed when Adriblastina is used -
Moderate
Mild
Common
Is the use of Adriblastina safe for pregnant women?
Adriblastina has many dangerous side effects in pregnant women. If you are pregnant, do not consume Adriblastina without medical advice.
Is the use of Adriblastina safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Adriblastina. So it is adviced to consult the doctor before using it.
What is the effect of Adriblastina on the Kidneys?
Using Adriblastina does not have any harmful effects on kidneys.
What is the effect of Adriblastina on the Liver?
Adriblastina may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Adriblastina on the Heart?
The heart can be affected by Adriblastina. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Adriblastina should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Adriblastina unless your doctor advises you to do so -
Is this Adriblastina habit forming or addictive?
Forming a habit of Adriblastina has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Adriblastina, you should not drive or work on any heavy machine, as Adriblastina can make you drowsy.
Is it safe?
Yes, but take Adriblastina only as per medical advice.
Is it able to treat mental disorders?
No, Adriblastina cannot treat any kind of mental disorder.
Interaction between Food and Adriblastina
Taking Adriblastina with food does not cause any problems.
Interaction between Alcohol and Adriblastina
Due to lack of research, there is no information about the side effects of taking Adriblastina with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 463-465
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 867
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Adriamycin (doxorubicin hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Doxorubicin Hydrochloride (doxorubicin hydrochloride)